Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Association of pulse pressure with fasting and 2-h plasma glucose in subjects with different degrees of glucose tolerance

Authors: Letícia Maria Tedesco Silva, Vanessa Piccoli, Barbara Limberger Nedel, Tássia Cividanes Pazinato, Leonardo de Andrade Mesquita, Luciana Pavan Antoniolli, Rodrigo Soares de Souza Marques, Fernando Gerchman

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Increased pulse pressure (PP) is a strong predictor of cardiovascular mortality and it has been associated with an increased risk of developing diabetes and its microvascular complications. However, the mechanism underlying the association between PP and abnormalities of glucose metabolism is unclear. …
Metadata
Title
Association of pulse pressure with fasting and 2-h plasma glucose in subjects with different degrees of glucose tolerance
Authors
Letícia Maria Tedesco Silva
Vanessa Piccoli
Barbara Limberger Nedel
Tássia Cividanes Pazinato
Leonardo de Andrade Mesquita
Luciana Pavan Antoniolli
Rodrigo Soares de Souza Marques
Fernando Gerchman
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A32

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine